Virulent Rhodococcus equi isolates from foals in Poland – pVapA characteristics and plasmid new variant, 85-kb type V  by Witkowski, L. et al.
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S83eS87S86were sampled. There was a marked intra and inter-lot variation
of all anti-VapA speciﬁc IgG concentrations (Table 1). When anti-
VapA speciﬁc IgG concentrations were compared between the
dam’s serum, R. equi HIP, and foal’s serum, either weak positive
or negative linear correlations were observed (-0.15 < r < 0.20),
with the exception of IgG(t), which showed a moderate positive
linear correlation between R. equi speciﬁc HIP, and foal’s serum
(r ¼ 0.71). Our results revealed an even greater variation in anti-
VapA speciﬁc IgG concentrations within and among the different
lots of the selected R. equi HIP product, than previously reported.
This ﬁnding may corroborate in explaining historical disparities
regarding R. equi speciﬁc HIP efﬁcacy in preventing R. equi
pneumonia in foals. The lack of a positive correlation between
the anti-VapA speciﬁc IgG concentrations between the dams,
HIP and the recipient foals is not fully understood. However,
possible explanations include suboptimal time sampling of the
dams, low anti-VapA speciﬁc IgG concentrations in adult horses,
and unknown antibody kinetics of the anti-VapA speciﬁc IgGs in
the recipient foal. Recently, it has been reported that after
intravenous administration of R. equi HIP, the concentrations of
anti-VapA speciﬁc IgGs in the bronchoalveolar ﬂuid increases,
suggesting compartmentalization of these antibodies outside
the systemic circulation. The moderate positive correlation
observed between the concentrations of IgG(t) between the R.
equi HIP and the recipient foals was likely due to its high con-
centration in the HIP product. Serial measurements of the foal’s
serum concentrations of anti-VapA speciﬁc IgGs is warranted in
order to evaluate their relationship with clinical disease, and
therefore the efﬁcacy of this commercially available R. equi HIP
in preventing naturally acquired pneumonia in foals.Table 1
Intra- and inter-lot coefﬁcient of variation (CV) of anti-VapA speciﬁc IgG
concentrations in different lots of R. equi HIP1.
CV(%)
Lot # IgG total IgGa IgGb IgGt
1 49.39 51.74 54.50 32.79
2 45.02 57.73 32.89 28.15
3 58.52 63.38 55.71 39.15
4 57.81 65.87 59.07 58.03
5* - - - -
6 39.18 55.54 46.33 47.53
7 60.43 61.40 59.22 58.09
8 70.83 91.88 79.37 31.83
9 51.96 56.79 71.16 52.33
10* - - - -
11* - - - -
All lots 60.88 62.70 87.63 90.97* Only one HIP bag was sampled.
Reference
[1] ImmunoGlo, MgBiologics, Aimes, Iowa, USA.
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Bronchopneumonia caused by Rhodococcus equi is an important
and often debilitating disease of young horses throughout the
world. Advances in diagnostic methods for the early detection
of lung lesions, such as ultrasonographic imaging, have been
associated with an increase in the use of antimicrobial agents
for the treatment of this disease. Concurrent with this increased
usage, reports of antimicrobial resistance in R. equi have
become more common in recent years. The aim of this study
was to determine the level of resistance to three commonly
prescribed antimicrobial agents in 97 virulent Rhodococcus equi
isolates collected from infected foals between 1991 and 2014.
The second objective was to determine the utility of a novel
assay for determining the minimum inhibitory concentration
(MIC) of R. equi isolates with a single agent, or when rifampicin
and erythromycin were combined. Three cohorts of virulent
Rhodococcus equi isolates were included in the study. Cohort 1
contained 29 isolates collected from clinical cases between
1991 and 1998 and Cohort 2 consisted of 12 recent isolates
collected between 2011 and 2014. Fifty six isolates from clini-
cally affected foals undergoing antimicrobial therapy in 2006 -
2007 on an endemically infected farm formed Cohort 3. The
MICs for rifampicin, erythromycin and neomycin were deter-
mined for all of the isolates using a novel microtitre assay.
Rifampicin resistance was detected in 3 of the 12 isolates in
Cohort 2. The MIC was 64 mg/mL for two of the isolates and 16
mg/mL for the third, well above the threshold of 8 mg/mL that
deﬁnes resistance to this agent. All isolates collected prior to
2013 had MICs less than 0.125 mg/mL (limit of detection). None
of the isolates were resistant to either neomycin or erythro-
mycin, with MIC values ranging from 0.25 - 2 mg/mL for
neomycin and 0.125 - 1 mg/mL for erythromycin. When rifam-
picin and erythromycin were tested in combination, the MIC
value for the isolates resistant to rifampicin were lower,
compared to exposure to rifampicin alone. This is the ﬁrst
report of rifampicin resistance in virulent R. equi isolated from
Australian foals. Sanger sequencing of a portion of the RNA
polymerase b subunit was conducted to further characterise the
resistant isolates from Cohort 2 [1], [2]. The current therapeutic
success of the macrolide - rifampicin combination regimen is
thought to rely on the synergistic action of these two agents in
vivo. It is not clear from these results whether the rifampicin
resistance we have detected has any signiﬁcant impact on
synergy in vivo.References
[1] Fines et al. (2001) J. Clin Micro 39(8): 2784-7.
[2] Zaczek et al. (2009) BMC Micro 9:10.
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Rhodococcus equi is one of the most important bacterial path-
ogens in foals up to six months of age worldwide. Prevalence
of rhodococcosis in foals in Poland is similar to other countries
and is endemic on some farms, and sporadic or even not
recognized on others. There is no information about plasmid
proﬁles of R. equi isolates in Poland. The virulent R. equi strains
carry virulence-associated plasmids (pVapA) the vapA gene
encoding virulence-associated 15e17-kDa protein (VapA).
Analysis of the restriction enzyme digestion patterns revealed
12 distinct pVAPA types (85-kb types IeIV, 87-kb types I-III
and 90-kb types IeV). Material for this study was collected on
13 horse breeding farms between 2001 and 2012. The R. equi
strains were isolated from tracheobronchial aspiration sam-
ples from foals with clinical rhodococcosis or from lung sam-
ples collected during necropsy. The presence of R. equi genes,
choE, traA and vapA was determined by PCR. Plasmid DNA was
isolated from the vapA-positive R. equi isolates using an alka-
line lysis method, with some modiﬁcation, and digested with
restriction endonucleases EcoRI, EcoT221, HindIII and BamHI.
Totally, 57 virulent strains were investigated. The 85-kb type I
plasmid was found in 48 strains (82,8 %) and 87-kb type I
plasmid in 8 strains (13,8%). One strain (1.7%) had a EcoRI
unique restriction cleavage pattern. This plasmid new variant
is similar to the 85 kb type I and was named “85-kb type V”
(Fig. 1). The 85-kb type I plasmid was found in 96.4% of foal
isolates in Germany, 95.3% in Hungary, 59.5% in France, 53.1%
in USA and 14.6% in Brazil. Moreover, in soil and environment
of the farms in Hungary (71.4% of soil isolates) and USA (64.5%
of isolates). The 87-kb type I plasmid is most widespread in
Brazil (80% of isolates). In Europe it was found in 3.6% of iso-
lates from foals in Germany, 4.7% from foals and 13.3% from
soil in Hungary, in 26% of isolates from foals in France and in
40.6% of isolates from foals and 26.4% from soil in Texas. This isthe ﬁrst report of the R. equi VapA plasmid proﬁles from
Poland.
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cellular pathogen. Its infection causes subacute or chronic
abscessating bronchopneumonia in foals up to 6 months. To
date, while China remains the largest equine population around
word, epidemiology of R. equi and its infection in horses re-
mains unknown. Thus, prevalence of R. equi in soil and its
infection in horses in Southern and Northern China were
investigated and compared. A total of 132 soil samples were
collected in horse farms. The virulent R. equi were detected by a
modiﬁed colony immunoblot assay, as well as classic bacteria
isolation and VapA PCR. In addition, a total of 136 sera samples
were collected from horses in corresponding farms. Seropre-
valence against virulent R. equi was evaluated by ELISA. The R.
equi was detected in all farms from both northern and southern
regions, although no virulent R. equi was isolated and detected.
However, sera-positive to VapA was detected in both regions.
The positive ratio was over 50% in horses from Northern China,
signiﬁcantly higher than that of Southern China. The positive
ratio varied between farms, seasons that samples were
collected. No virulent R. equi in China maybe due to low
pathogenesis of the bacteria to local horses. This was under
investigation.
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